Scar wars: is TGFβ the phantom menace in scleroderma?
Open Access
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 8 (4), 213
- https://doi.org/10.1186/ar1976
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK: Insights into Pathological Scarring in Chronic Fibrotic DiseaseThe American Journal of Pathology, 2005
- Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblastsArthritis & Rheumatism, 2003
- Liver extracellular matrix in health and diseaseThe Journal of Pathology, 2003
- Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcomeGene Therapy, 2003
- The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and ApoptosisJournal of Bone and Mineral Research, 2001
- Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4JCI Insight, 2001
- Expression of TGF-β1, -β2 and -β3 in localized and systemic sclerodermaJournal of Dermatological Science, 1999
- The modular architecture of a new family of growth regulators related to connective tissue growth factorFEBS Letters, 1993
- Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: Insensitivity to TGFβ1 stimulationBiochemical and Biophysical Research Communications, 1992
- Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-βScience, 1987